Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Dasatinib-Teva |
| Active Ingredient: | Dasatinib monohydrate 20.739mg equivalent to dasatinib 20mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | PLIVA Croatia Limited, Zagreb, Croatia |
| Product: | Dasatinib-Teva |
| Active Ingredient: | Dasatinib monohydrate 51.847mg equivalent to dasatinib 50mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | PLIVA Croatia Limited, Zagreb, Croatia |
| Product: | Dasatinib-Teva |
| Active Ingredient: | Dasatinib monohydrate 72.585mg equivalent to dasatinib 70mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | PLIVA Croatia Limited, Zagreb, Croatia |
| Product: | Dasatinib-Teva |
| Active Ingredient: | Dasatinib monohydrate 103.693mg equivalent to dasatinib 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | PLIVA Croatia Limited, Zagreb, Croatia |
| Product: | Gutron |
| Active Ingredient: | Midodrine hydrochloride 2.5mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Takeda GmbH, Oranienburg, Germany |
| Product: | Gutron |
| Active Ingredient: | Midodrine hydrochloride 5mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Takeda GmbH, Oranienburg, Germany |
Dated this 9th day of April 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).